Joint Venture (Amyris / ImmunityBio) Overview

  • Status
  • Private

  • Latest Deal Type
  • Joint Venture

  • Financing Rounds
  • 1

Joint Venture (Amyris / ImmunityBio) General Information

Description

Developer of RNA COVID-19 vaccine dedicated to accelerating the commercialization of the vaccine.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Corporate Backed or Acquired
Corporate Office
  • 3530 John Hopkins Court
  • San Diego, CA 92121
  • United States
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Life Sciences
Corporate Office
  • 3530 John Hopkins Court
  • San Diego, CA 92121
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Joint Venture (Amyris / ImmunityBio) Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA		 Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Joint Venture (Amyris / ImmunityBio)‘s full profile, request access.

Request a free trial

Joint Venture (Amyris / ImmunityBio) Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Joint Venture (Amyris / ImmunityBio)‘s full profile, request access.

Request a free trial

Joint Venture (Amyris / ImmunityBio) FAQs

  • Where is Joint Venture (Amyris / ImmunityBio) headquartered?

    Joint Venture (Amyris / ImmunityBio) is headquartered in San Diego, CA.

  • What industry is Joint Venture (Amyris / ImmunityBio) in?

    Joint Venture (Amyris / ImmunityBio)’s primary industry is Drug Discovery.

  • Is Joint Venture (Amyris / ImmunityBio) a private or public company?

    Joint Venture (Amyris / ImmunityBio) is a Private company.

  • What is Joint Venture (Amyris / ImmunityBio)’s current revenue?

    The current revenue for Joint Venture (Amyris / ImmunityBio) is .

  • Who are Joint Venture (Amyris / ImmunityBio)’s investors?

    Amyris (Biotechnology) and ImmunityBio have invested in Joint Venture (Amyris / ImmunityBio).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more

  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process